Back to Search
Start Over
TWO-YEAR CLINICAL OUTCOMES AFTER PHOTODYNAMIC ACUTE EXUDATIVE MACULOPATHY IN PATIENTS WITH CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
- Source :
-
Retina (Philadelphia, Pa.) [Retina] 2023 Nov 01; Vol. 43 (11), pp. 1988-1995. - Publication Year :
- 2023
-
Abstract
- Purpose: To analyze the 2-year clinical outcomes after photodynamic therapy-induced acute exudative maculopathy (PAEM) in patients with chronic central serous chorioretinopathy.<br />Methods: Prospective observational study that included 64 eyes of 64 patients with chronic central serous chorioretinopathy who received half-fluence photodynamic therapy and had a 2-year follow-up. Patients were classified into two groups based on whether they had had PAEM at 3 days after treatment (PAEM+, n = 22; ≥50 µ m) increase in subretinal fluid or not (PAEM-, n = 42). Best-corrected visual acuity and subretinal fluid changes evaluated with optical coherence tomography were registered at 3 days, 1 month, 3 months, 1 year, and 2 years after photodynamic therapy. The number of recurrences, the appearance of outer retinal atrophy, and choroidal neovascularization were analyzed.<br />Results: Best-corrected visual acuity was 75.9 ± 13.6 (20/32) and 82.0 ± 11.0 letters (20/25) at 2 years in the PAEM+ and PAEM- groups, respectively ( P = 0.055). There were no differences in the best-corrected visual acuity change (4.2 ± 7.7 vs. 3.3 ± 7.1 letters; P = 0.654) and the subretinal fluid decrease (-117.3 ± 74.2 vs. -138.5 ± 83.6 µ m; P = 0.323) at 2 years between patients with and without PAEM. No differences in the number of recurrences ( P = 0.267), the appearance of choroidal neovascularization ( P = 0.155), or outer retinal atrophy ( P = 0.273) between both groups were noted.<br />Conclusion: Patients with chronic central serous chorioretinopathy with and without PAEM presented similar results at 2 years in best-corrected visual acuity gain, subretinal fluid reduction, and complication rate.
- Subjects :
- Humans
Atrophy pathology
Chronic Disease
Fluorescein Angiography
Photosensitizing Agents adverse effects
Retina pathology
Retrospective Studies
Tomography, Optical Coherence
Treatment Outcome
Visual Acuity
Central Serous Chorioretinopathy diagnosis
Central Serous Chorioretinopathy drug therapy
Central Serous Chorioretinopathy pathology
Choroidal Neovascularization drug therapy
Macular Degeneration drug therapy
Photochemotherapy methods
Subjects
Details
- Language :
- English
- ISSN :
- 1539-2864
- Volume :
- 43
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Retina (Philadelphia, Pa.)
- Publication Type :
- Academic Journal
- Accession number :
- 37343292
- Full Text :
- https://doi.org/10.1097/IAE.0000000000003876